Literature DB >> 11917032

The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure.

Hanno Scheffczik1, Christos G W Savva, Andreas Holzenburg, Larissa Kolesnikova, Elke Bogner.   

Abstract

Herpesvirus DNA packaging involves binding and cleavage of DNA containing the specific DNA-packaging motifs. Here we report a first characterization of the terminase subunits pUL56 and pUL89 of human cytomegalovirus (HCMV). Both gene products were shown to have comparable nuclease activities in vitro. Under limiting protein concentrations the nuclease activity is enhanced by interaction of pUL56 and pUL89. High amounts of 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole partially inhibited the pUL89-associated nuclease activity. It was demonstrated that pUL56 is able to bind to nucleocapsids in vivo. Electron microscopy (EM) and image analysis of purified pUL56 revealed that the molecules occurred as a distinct ring-shaped structure with a pronounced cleft. EM analysis of purified pUL89 demonstrated that this protein is also a toroidal DNA-metabolizing protein. Upon interaction of pUL56 with linearized DNA, the DNA remains uncut while the cutting event itself is mediated by pUL89. Using biochemical assays in conjunction with EM pUL56 was shown to (i) bind to DNA and (ii) associate with the capsid. In contrast to this, EM analysis implied that pUL89 is required to effect DNA cleavage. The data provide the first insights into the terminase-dependent viral DNA-packaging mechanism of HCMV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11917032      PMCID: PMC101837          DOI: 10.1093/nar/30.7.1695

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  39 in total

1.  The herpes simplex virus type 1 U(L)17 gene encodes virion tegument proteins that are required for cleavage and packaging of viral DNA.

Authors:  B Salmon; C Cunningham; A J Davison; W J Harris; J D Baines
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 2.  Toroidal proteins: running rings around DNA.

Authors:  M M Hingorani; M O'Donnell
Journal:  Curr Biol       Date:  1998-01-29       Impact factor: 10.834

3.  The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes.

Authors:  R R Spaete; E S Mocarski
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

Review 4.  Head morphogenesis of complex double-stranded deoxyribonucleic acid bacteriophages.

Authors:  H Murialdo; A Becker
Journal:  Microbiol Rev       Date:  1978-09

5.  An x-ray small angle study of the bacteriophages fr and R17.

Authors:  P Zipper; O Kratky; R Herrmann; T Hohn
Journal:  Eur J Biochem       Date:  1971-01-01

6.  The product of the herpes simplex virus type 1 UL25 gene is required for encapsidation but not for cleavage of replicated viral DNA.

Authors:  A R McNab; P Desai; S Person; L L Roof; D R Thomsen; W W Newcomb; J C Brown; F L Homa
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Functional analysis of the DNA-packaging/terminase protein gp17 from bacteriophage T4.

Authors:  D Kuebler; V B Rao
Journal:  J Mol Biol       Date:  1998-09-04       Impact factor: 5.469

8.  Human cytomegalovirus: purification of enveloped virions and dense bodies.

Authors:  P Talbot; J D Almeida
Journal:  J Gen Virol       Date:  1977-08       Impact factor: 3.891

9.  Herpes simplex virus type 1 cleavage and packaging proteins UL15 and UL28 are associated with B but not C capsids during packaging.

Authors:  D Yu; S K Weller
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56.

Authors:  P M Krosky; M R Underwood; S R Turk; K W Feng; R K Jain; R G Ptak; A C Westerman; K K Biron; L B Townsend; J C Drach
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

View more
  53 in total

1.  Minimal cis-acting elements required for adenovirus genome packaging.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.

Authors:  Marta Nadal; Philippe J Mas; Phillipe J Mas; Alexandre G Blanco; Carme Arnan; Maria Solà; Darren J Hart; Miquel Coll
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

3.  The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.

Authors:  Thomas Goldner; Guy Hewlett; Nicole Ettischer; Helga Ruebsamen-Schaeff; Holger Zimmermann; Peter Lischka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

4.  The effect of N- or C-terminal alterations of the connector of bacteriophage phi29 DNA packaging motor on procapsid assembly, pRNA binding, and DNA packaging.

Authors:  Ying Cai; Feng Xiao; Peixuan Guo
Journal:  Nanomedicine       Date:  2008-01-16       Impact factor: 5.307

5.  Intracellular Distribution of Capsid-Associated pUL77 of Human Cytomegalovirus and Interactions with Packaging Proteins and pUL93.

Authors:  Pánja Köppen-Rung; Alexandra Dittmer; Elke Bogner
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

6.  Human cytomegalovirus (HCMV) and hearing impairment: infection of fibroblast cells with HCMV induces chromosome breaks at 1q23.3, between loci DFNA7 and DFNA49 -- both involved in dominantly inherited, sensorineural, hearing impairment.

Authors:  Mona Nystad; Toril Fagerheim; Vigdis Brox; Elizabeth A Fortunato; Øivind Nilssen
Journal:  Mutat Res       Date:  2007-07-25       Impact factor: 2.433

7.  Impact of 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole riboside and inhibitors of DNA, RNA, and protein synthesis on human cytomegalovirus genome maturation.

Authors:  Michael A McVoy; Daniel E Nixon
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

9.  Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.

Authors:  David L Evers; Gloria Komazin; Roger G Ptak; Dongjin Shin; Brian T Emmer; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Susceptibilities of human cytomegalovirus clinical isolates and other herpesviruses to new acetylated, tetrahalogenated benzimidazole D-ribonucleosides.

Authors:  Jae-Seon Hwang; Rita Schilf; John C Drach; Leroy B Townsend; Elke Bogner
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.